Method for treatment of glycolipid storage diseases
US6610703B1 · kind B1 · utility
36Cited by
5References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 2, 1999 |
| Grant date | Aug 26, 2003 |
| Priority date | — |
| Expiry date | Dec 2, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel method is disclosed for the treatment of a patient affected with Gaucher's disease or other such glycolipid storage diseases. The method comprises administering to said patient a therapeutically effective amount of a long-chain N-alkyl derivative of deoxynojirimycin to alleviate or inhibit the glycolipid storage disease. The long-chain alkyl group has from nine to about 20 carbon atoms and preferably is nonyl or decyl.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.